Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
Fierce Pharma
Mon, 03/13/17 - 10:18 am
Tags:
Merck, Pfizer, SGLT2 inhibitor, diabetes, ertugliflozin, Jardiance, Boehringer Ingelheim, Eli Lilly, JNJ, Invokana, AstraZeneca, Farxiga
AstraZeneca CEO Soriot counts up £13.4M in 2016 pay, a 68% hike
Fierce Pharma
Wed, 03/8/17 - 05:32 pm
Tags:
AstraZeneca, Pascal Soriot, Pharma CEOs, executive pay
Sanofi steps up with a $645M deal to partner with AstraZeneca on a late-stage RSV antibody
Endpoints
Fri, 03/3/17 - 09:24 am
Tags:
Sanofi, AstraZeneca, RSV, MEDI8897
Emerging Markets Expected to Be AstraZeneca’s Key Growth Driver
Market Realist
Thu, 03/2/17 - 09:38 am
Tags:
emerging markets, AstraZeneca
AstraZeneca Has Started a Turnaround
TheStreet.com
Mon, 02/27/17 - 10:14 pm
Tags:
AstraZeneca
Nasal flu vaccine may not be recommended for use in US for years
Stat
Fri, 02/24/17 - 09:13 am
Tags:
flu vaccines, nasal flu vaccine, FluMist, AstraZeneca, MedImmune
AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex
Fierce Pharma
Tue, 02/21/17 - 11:14 am
Tags:
AstraZeneca, Zoladex, TerSera Therapeutics
Clovis, Tesaro Soar on Astrazeneca Phase Three News
TheStreet.com
Sat, 02/18/17 - 02:37 pm
Tags:
Clovis Oncology, Tesaro, AstraZeneca, clinical trials, Lynparza, breast cancer
AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial
TheStreet.com
Fri, 02/17/17 - 11:02 am
Tags:
AstraZeneca, Lynparza, breast cancer
With Siliq approval, can Amgen and AZ's trash become Valeant's treasure?
Fierce Pharma
Thu, 02/16/17 - 10:11 am
Tags:
Siliq, Amgen, AstraZeneca, Valeant Pharmaceuticals, chronic plaque psoriasis
Checkpoint inhibitors set to face off in bladder cancer
BioPharma Dive
Wed, 02/8/17 - 09:48 am
Tags:
bladder cancer, Bristol-Myers Squibb, Opdivo, Merck, Keytruda, Roche, Tecentriq, AstraZeneca, durvalumab
AZ chief: Durvalumab's ready for a 'marketing battle' against I-O heavyweights Opdivo, Keytruda
Fierce Pharma
Tue, 02/7/17 - 10:25 am
Tags:
immuno-oncology, AstraZeneca, durvalumab, Pascal Soriot, Merck, Keytruda, Bristol-Myers Squibb, Opdivo
Astrazeneca posts 4Q profit
Yahoo/AP
Thu, 02/2/17 - 09:26 am
Tags:
AstraZeneca, earnings
Old drug gets new trick for prostate cancer treatment
Stat
Thu, 02/2/17 - 09:24 am
Tags:
prostate cancer, AstraZeneca, ADT, bicalutamide
AstraZeneca’s Asthma Drug Receives Expanded Indication from FDA
Xtalks
Wed, 02/1/17 - 09:33 am
Tags:
AstraZeneca, asthma, FDA, Symbicort, pediatrics
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:36 pm
Tags:
Merck, Sanofi, Eli Lilly, Pfizer, Roche, AstraZeneca, Gilead Sciences, Allergan, GSK
AZ nabs 6 more months of Symbicort exclusivity—and the sales that come with it
Fierce Pharma
Fri, 01/27/17 - 09:28 am
Tags:
AstraZeneca, Symbicort, exclusivity, pediatrics, asthma
AstraZeneca angles for more competitive position in immuno-oncology
BioPharma Dive
Thu, 01/19/17 - 11:19 am
Tags:
AstraZeneca, immuno-oncology, tremelimumab, durvalumab
AstraZeneca delays PD-L1 data in rejig of phase 3 program
Fierce Biotech
Tue, 01/17/17 - 10:02 am
Tags:
AstraZeneca, anti-PD-L1, clinical trials, tremelimumab, durvalumab
Biogen spinoff begins trading today; New oncology chief at AstraZeneca
Endpoints
Fri, 01/13/17 - 11:18 am
Tags:
Biogen, AstraZeneca, oncology, hemophilia, Bioverativ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.